CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cytarabine

阿糖胞苷 杂质对照品Cytarabine Impurities

EP51 个杂质条目51 impurity entries

本页汇总 阿糖胞苷 的 51 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 51 impurity reference standards of Cytarabine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿糖胞苷(Cytarabine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDrug-Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy
    Molecular pharmaceutics · 2024 · Yu YM et al.  ·  PMID 39392428  ·  DOI
  2. 杂质研究Impurity studiesPhysical and chemical stability of cytarabine in polypropylene syringes
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2021 · Ayed WB et al.  ·  PMID 32605496  ·  DOI
  3. 杂质研究Impurity studiesStability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2012 · D'Hondt M et al.  ·  PMID 22261946  ·  DOI
  4. 分析方法Analytical MethodsDetermination of free and encapsulated cytarabine and daunorubicin in rat plasma after intravenous administration of liposomal formulation using ultra-high performance liquid chromatography tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2022 · Li S et al.  ·  PMID 35551041  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers
    International journal of pharmaceutics · 2011 · Sarpietro MG et al.  ·  PMID 21219999  ·  DOI

阿糖胞苷 —— 原料药与杂质对照品Cytarabine — drug substance & impurities

共 52 个条目(含原料药本体)52 items incl. the drug substance
Cytarabine structure
EP原料药 APIAPI
阿糖胞苷Cytarabine
Cytarabine
CAS No.147-94-4
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 5(Cytarabine EP Impurity A) structure
EPA
阿糖胞苷杂质5(阿糖胞苷EP杂质A)Cytarabine Impurity 5(Cytarabine EP Impurity A)
Cytarabine Impurity 5(Cytarabine EP Impurity A)
CAS No.3083-77-0
Chemical FormulaC9H12N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 10(Cytarabine EP Impurity F) structure
EPF
阿糖胞苷杂质10(阿糖胞苷EP杂质F)Cytarabine Impurity 10(Cytarabine EP Impurity F)
Cytarabine Impurity 10(Cytarabine EP Impurity F)
CAS No.32830-01-6
Chemical FormulaC9H11N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 17(Cytarabine EP Impurity G) structure
EPG
阿糖胞苷杂质17(阿糖胞苷EP杂质G)Cytarabine Impurity 17(Cytarabine EP Impurity G)
Cytarabine Impurity 17(Cytarabine EP Impurity G)
CAS No.2140-61-6
Chemical FormulaC10H15N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 11(Cytarabine EP Impurity I) structure
EPI
阿糖胞苷杂质11(阿糖胞苷EP杂质I)Cytarabine Impurity 11(Cytarabine EP Impurity I)
Cytarabine Impurity 11(Cytarabine EP Impurity I)
CAS No.6829-31-8
Chemical FormulaC10H15N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 16-13C (Cytarabine EP Impurity B-13C) structure
EPB-13C
阿糖胞苷杂质16-13C (阿糖胞苷EP杂质B-13C)Cytarabine Impurity 16-13C (Cytarabine EP Impurity B-13C)
Cytarabine Impurity 16-13C (Cytarabine EP Impurity B-13C)
CAS No.201996-62-5
Chemical FormulaC813CH12N2O6
Purity>95%询价On request
10mg25mg50mg100mg
2'-CMP structure
—
阿糖胞苷杂质592'-CMP
2'-CMP
CAS No.85-94-9
Chemical FormulaC9H14N3O8P
Purity>95%现货In stock
Cytarabine Impurity 4 structure
4
阿糖胞苷杂质4Cytarabine Impurity 4
Cytarabine Impurity 4
CAS No.18265-49-1
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 8 structure
8
阿糖胞苷杂质8Cytarabine Impurity 8
Cytarabine Impurity 8
CAS No.7075-11-8
Chemical FormulaC9H14N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 9(L-Aspartate-Cytarabine) structure
9
阿糖胞苷杂质9(L-天冬氨酸阿糖胞苷)Cytarabine Impurity 9(L-Aspartate-Cytarabine)
Cytarabine Impurity 9(L-Aspartate-Cytarabine)
CAS No.2098942-53-9
Chemical FormulaC13H18N4O8
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 12 structure
12
阿糖胞苷杂质12Cytarabine Impurity 12
Cytarabine Impurity 12
CAS No.14057-18-2
Chemical FormulaC15H18N2O9
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 13 structure
13
阿糖胞苷杂质13Cytarabine Impurity 13
Cytarabine Impurity 13
CAS No.82855-62-7
Chemical FormulaC17H19N5O8
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 15 structure
15
阿糖胞苷杂质15Cytarabine Impurity 15
Cytarabine Impurity 15
CAS No.13913-16-1
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 19 (2'-Deoxyuridine) structure
19
阿糖胞苷杂质19 (2'-脱氧尿苷)Cytarabine Impurity 19 (2'-Deoxyuridine)
Cytarabine Impurity 19 (2'-Deoxyuridine)
CAS No.951-78-0
Chemical FormulaC9H12N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 20(2'-Deoxycytidine) structure
20
阿糖胞苷杂质20(2-脱氧胞苷)Cytarabine Impurity 20(2'-Deoxycytidine)
Cytarabine Impurity 20(2'-Deoxycytidine)
CAS No.951-77-9
Chemical FormulaC9H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 21 structure
21
阿糖胞苷杂质21Cytarabine Impurity 21
Cytarabine Impurity 21
CAS No.10212-25-6
Chemical FormulaC9H11N3O4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 21 Monomer structure
21
阿糖胞苷杂质21 单体Cytarabine Impurity 21 Monomer
Cytarabine Impurity 21 Monomer
CAS No.31698-14-3
Chemical FormulaC9H11N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 26 structure
26
阿糖胞苷杂质26Cytarabine Impurity 26
Cytarabine Impurity 26
CAS No.10212-22-3
Chemical FormulaC9H14N4O4
Purity>95%现货In stock
10mg25mg50mg100mg
Cytarabine Impurity 34 structure
34
阿糖胞苷杂质34Cytarabine Impurity 34
Cytarabine Impurity 34
CAS No.19921-43-8
Chemical FormulaC4H5N3O
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 36 structure
36
阿糖胞苷杂质36Cytarabine Impurity 36
Cytarabine Impurity 36
CAS No.84902-98-7
Chemical FormulaC4H6N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 38 structure
38
阿糖胞苷杂质38Cytarabine Impurity 38
Cytarabine Impurity 38
CAS No.26889-42-9
Chemical FormulaC9H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 40 structure
40
阿糖胞苷杂质40Cytarabine Impurity 40
Cytarabine Impurity 40
CAS No.800-73-7
Chemical FormulaC9H15N3O10P2
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 41 structure
41
阿糖胞苷杂质41Cytarabine Impurity 41
Cytarabine Impurity 41
CAS No.154568-81-7
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 42 structure
42
阿糖胞苷杂质42Cytarabine Impurity 42
Cytarabine Impurity 42
CAS No.16033-23-1
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 43 structure
43
阿糖胞苷杂质43Cytarabine Impurity 43
Cytarabine Impurity 43
CAS No.7428-39-9
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 44 structure
44
阿糖胞苷杂质44Cytarabine Impurity 44
Cytarabine Impurity 44
CAS No.218452-08-5
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 45 structure
45
阿糖胞苷杂质45Cytarabine Impurity 45
Cytarabine Impurity 45
CAS No.16110-07-9
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 46 structure
46
阿糖胞苷杂质46Cytarabine Impurity 46
Cytarabine Impurity 46
CAS No.77172-20-4
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 47 structure
47
阿糖胞苷杂质47Cytarabine Impurity 47
Cytarabine Impurity 47
CAS No.27921-78-4
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 48 structure
48
阿糖胞苷杂质48Cytarabine Impurity 48
Cytarabine Impurity 48
CAS No.201681-19-8
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 49 structure
49
阿糖胞苷杂质49Cytarabine Impurity 49
Cytarabine Impurity 49
CAS No.179239-81-7
Chemical FormulaC9H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 60 structure
60
阿糖胞苷杂质60Cytarabine Impurity 60
Cytarabine Impurity 60
CAS No.84-52-6
Chemical FormulaC9H14N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 62 structure
62
阿糖胞苷杂质62Cytarabine Impurity 62
Cytarabine Impurity 62
CAS No.60827-79-4
Chemical FormulaC11H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 64 structure
64
阿糖胞苷杂质64Cytarabine Impurity 64
Cytarabine Impurity 64
CAS No.1034370-69-8
Chemical FormulaC14H21N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 65 structure
65
阿糖胞苷杂质65Cytarabine Impurity 65
Cytarabine Impurity 65
CAS No.55062-63-0
Chemical FormulaC11H17N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 66 structure
66
阿糖胞苷杂质66Cytarabine Impurity 66
Cytarabine Impurity 66
CAS No.1166395-05-6
Chemical FormulaC10H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 71 structure
71
阿糖胞苷杂质71Cytarabine Impurity 71
Cytarabine Impurity 71
CAS No.30902-36-4
Chemical FormulaC9H13N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 74 structure
74
阿糖胞苷杂质74Cytarabine Impurity 74
Cytarabine Impurity 74
CAS No.2434654-73-4
Chemical FormulaC38H46N5O5P
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 75 (5-Methyl-2'-deoxycytidine) structure
75
阿糖胞苷杂质75 (5-甲基-2'-脱氧胞苷)Cytarabine Impurity 75 (5-Methyl-2'-deoxycytidine)
Cytarabine Impurity 75 (5-Methyl-2'-deoxycytidine)
CAS No.838-07-3
Chemical FormulaC10H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 76 structure
76
阿糖胞苷杂质76Cytarabine Impurity 76
Cytarabine Impurity 76
CAS No.7226-77-9
Chemical FormulaC10H15N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 77 structure
77
阿糖胞苷杂质77Cytarabine Impurity 77
Cytarabine Impurity 77
CAS No.32909-05-0
Chemical FormulaC11H15N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 78 structure
78
阿糖胞苷杂质78Cytarabine Impurity 78
Cytarabine Impurity 78
CAS No.48212-99-3
Chemical FormulaC17H19N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 79 structure
79
阿糖胞苷杂质79Cytarabine Impurity 79
Cytarabine Impurity 79
CAS No.110522-75-3
Chemical FormulaC13H19N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 81 structure
81
阿糖胞苷杂质81Cytarabine Impurity 81
Cytarabine Impurity 81
CAS No.51391-96-9
Chemical FormulaC10H13N3O4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
81
阿糖胞苷杂质81 单体Cytarabine Impurity 81 Monomer
Cytarabine Impurity 81 Monomer
CAS No.763867-43-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 82 structure
82
阿糖胞苷杂质82Cytarabine Impurity 82
Cytarabine Impurity 82
CAS No.68498-26-0
Chemical FormulaC11H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 83 structure
83
阿糖胞苷杂质83Cytarabine Impurity 83
Cytarabine Impurity 83
CAS No.4603-72-9
Chemical FormulaC9H11N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 84 structure
84
阿糖胞苷杂质84Cytarabine Impurity 84
Cytarabine Impurity 84
CAS No.652130-27-3
Chemical FormulaC23H19N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 85 structure
85
阿糖胞苷杂质85Cytarabine Impurity 85
Cytarabine Impurity 85
CAS No.24380-35-6
Chemical FormulaC16H18N2O8S
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 86 structure
86
阿糖胞苷杂质86Cytarabine Impurity 86
Cytarabine Impurity 86
CAS No.3063-71-6
Chemical FormulaC20H31N4O16P
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 87 (Mixture of E/Z-isomers) structure
87
阿糖胞苷杂质87 (混合E/Z构型)Cytarabine Impurity 87 (Mixture of E/Z-isomers)
Cytarabine Impurity 87 (Mixture of E/Z-isomers)
CAS No.61042-97-5
Chemical FormulaC4H5N3O
Purity>95%询价On request
10mg25mg50mg100mg
Cytarabine Impurity 88 structure
88
阿糖胞苷杂质88Cytarabine Impurity 88
Cytarabine Impurity 88
CAS No.4625-13-2
Chemical FormulaC8H12O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿糖胞苷 —— 研究文献与合成路线Cytarabine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿糖胞苷 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cytarabine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Determination of the antileukemia agents cytarabine and azacitidine and their respective degradation products by high-performance liquid chromatography
    Kissinger LD, Stemm NL · Journal of chromatography · 1986 · 被引 21cited 21
  2. Degradation of cytostatics methotrexate and cytarabine through physico-chemical and advanced oxidative processes: influence of pH and combined processes on the treatment efficiency
    Pimentel-Almeida W, Testolin RC, Gaspareto P, et al. · Environmental technology · 2024 · 被引 1cited 1
  3. Highly sensitive high-performance liquid chromatographic assay for 1-beta-D-arabinofuranosylcytosine-5'-stearyl phosphate (cytarabine-ocfosfate)
    Ramsauer B, Braess J, Unterhalt M, et al. · Journal of chromatography. B, Biomedical applications · 1995 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. PRODRUG BASED ON CYTARABINE STRUCTURE AS WELL AS SYNTHESIZING METHOD AND APPLICATION THEREOF
    LI WENBAO, XUE XIAOXIA, LI GANG, WANG RONGZHOU, et al. · 公开号 WO2011079501WO2011079501 · 2011
  2. Preparing method for cytarabine
    JIN CHUNHUA, WU ZHONGWEI, JIA GUORONG · 公开号 CN1583776CN1583776 · 2005
  3. Cytarabine derivatives, the preparation and use thereof
    KLUGE MICHAEL, SCHOTT HERBERT · 公开号 US5641758US5641758 · 1997

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿糖胞苷 杂质谱研究要点Cytarabine — impurity profiling notes

下面这些是拿到 阿糖胞苷 的 52 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 52 impurity entries for Cytarabine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances